Marsida Saraci
@Alphabet Inc.
Latest period2024 - Q3ReportedManaged Assets$1.842BTotal holdings42
Assets growth rate-6.69%Assets growth rate (2-Q avg)-14.07%Continuous growth in asset value0 quarters
Portfolio positions
This chart displays the top 10 holdings in Alphabet Inc.'s 2024 - Q3 portfolio, based on their 13F SEC filing, out of a total of 42 positions.
Assets under management
The assets under management (AUM) of Alphabet Inc. over the past 10 years (40 quarters) show continuous growth in total asset value over the last 0 quarters. As of the latest 13F SEC filing for 2024 - Q3, they manage 1.842B in assets, with a quarterly growth rate of -6.69% and a 2-quarter average growth rate of -14.07%. The portfolio is managed by Marsida Saraci, and others.
Portfolio holdings
Investment | Portfolio % | Reported Value | Recent Activity |
---|---|---|---|
GTLBGitlab Inc
| 27.31% | $502.944M 9.758M shares@ $51.55 avg price | |
ARMArm Holdings Plc
| 15.23% | $280.412M 1.961M shares@ $143.02 avg price | |
RVMDRevolution Medicines Inc
| 10.48% | $193.018M 4.256M shares@ $45.35 avg price | Decreased -19.8% |
FRSHFreshworks Inc
| 10.11% | $186.052M 16.207M shares@ $11.49 avg price | Increased 31.37% |
CRWDCrowdstrike Hldgs Inc
| 6.52% | $120.012M 427,895 shares@ $280.48 avg price | |
PATHUipath Inc
| 4.89% | $90.04M 7.034M shares@ $12.81 avg price | |
TEMTempus Ai Inc
| 4.77% | $87.792M 1.551M shares@ $56.6 avg price | |
PLPlanet Labs Pbc
| 3.87% | $71.232M 31.943M shares@ $2.23 avg price | |
DXCMDexcom Inc
| 3.78% | $69.516M 1.037M shares@ $67.04 avg price | |
VERVVerve Therapeutics Inc
| 3.25% | $59.77M 12.349M shares@ $4.84 avg price |